Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BioMarin Pharmaceutical (BMRN)

BioMarin Pharmaceutical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BMRN
DateTimeSourceHeadlineSymbolCompany
03/12/202423:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
16/11/202415:45PR Newswire (US)BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024NASDAQ:BMRNBioMarin Pharmaceutical Inc
14/11/202419:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
12/11/202419:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
06/11/202413:00PR Newswire (US)BioMarin to Participate in Three Upcoming Investor ConferencesNASDAQ:BMRNBioMarin Pharmaceutical Inc
31/10/202419:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BMRNBioMarin Pharmaceutical Inc
29/10/202420:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
29/10/202420:03PR Newswire (US)BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and OutlookNASDAQ:BMRNBioMarin Pharmaceutical Inc
24/10/202411:00GlobeNewswire Inc.Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug CandidateNASDAQ:BMRNBioMarin Pharmaceutical Inc
16/10/202412:30PR Newswire (US)BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ETNASDAQ:BMRNBioMarin Pharmaceutical Inc
01/10/202420:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
01/10/202420:50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
30/09/202420:29Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BMRNBioMarin Pharmaceutical Inc
24/09/202412:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
18/09/202412:00PR Newswire (US)BioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO® (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at 2024 International Skeletal Dysplasia Society MeetingNASDAQ:BMRNBioMarin Pharmaceutical Inc
17/09/202421:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
04/09/202417:00PR Newswire (US)BioMarin Holds Investor Day; Provides New Corporate Strategy and Introduces 2027 Financial GuidanceNASDAQ:BMRNBioMarin Pharmaceutical Inc
04/09/202416:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
04/09/202411:30PR Newswire (US)BioMarin to Host Investor Day Today at 10:30 a.m. Eastern TimeNASDAQ:BMRNBioMarin Pharmaceutical Inc
29/08/202412:00PR Newswire (US)BioMarin to Present at the 22nd Annual Morgan Stanley Global Healthcare Conference on Thursday, September 5 at 7:45 AM PT / 10:45 AM ET in New York, NYNASDAQ:BMRNBioMarin Pharmaceutical Inc
28/08/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
22/08/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
21/08/202412:30PR Newswire (US)BioMarin Announces New R&D and Business Development LeadershipNASDAQ:BMRNBioMarin Pharmaceutical Inc
19/08/202413:00PR Newswire (US)BioMarin to Host 2024 Investor Day on September 4th in New YorkNASDAQ:BMRNBioMarin Pharmaceutical Inc
15/08/202419:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
13/08/202415:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
05/08/202420:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BMRNBioMarin Pharmaceutical Inc
05/08/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
05/08/202420:03PR Newswire (US)BioMarin Announces 20% Y/Y Total Revenue Growth in the Second Quarter and Increase in Full-year 2024 GuidanceNASDAQ:BMRNBioMarin Pharmaceutical Inc
05/08/202420:01PR Newswire (US)BioMarin Announces Updated Strategy for ROCTAVIAN® to Focus on U.S., Germany and ItalyNASDAQ:BMRNBioMarin Pharmaceutical Inc
 Showing the most relevant articles for your search:NASDAQ:BMRN

Your Recent History

Delayed Upgrade Clock